"Children’s “specials” need to be more easily available" - An article published by PJ Online


Please click here to view this PJ Online article published 17/02/2011

Comments

Post a Comment

Popular posts from this blog

Specials medicines vital for vulnerable patients

During the COVID-19 outbreak, APSM members are taking all appropriate measures to ensure the continuity of supply of specials medicines to community pharmacies, dispensing doctors and hospitals.   Specials manufacturers are a vital part of the pharmaceutical supply chain, responsible for around 50,000 unlicensed medicine prescriptions for vulnerable patients in England each month.  The Association of Pharmaceutical Specials Manufacturers represents around 80% of specials manufacture in England and its members are maintaining safe practices and committing to the ongoing fulfilment of all orders from their pharmacy customers throughout the pandemic. As specials are often prescribed to patients in vulnerable groups including the elderly, paediatrics and those with chronic health conditions, it has never been more important that these patients’ essential medication needs are met in a timely way.  Where possible, our members are continuing to meet thei...
Read more

APSM expands membership to reflect changing role of specials industry

The Association of Pharmaceutical Specials Manufacturers, APSM, has broadened its membership criteria to include importers as well as virtual Specials manufacturing organisations who own the rights to, and act as the first supplier of, a Specials medicine in the UK. Originally founded to represent the interests of holders of a Specials Manufacturing Licence, the APSM has an important role liaising with the DH and key policy makers as well as inputting into decisions around new legislation and Specials guidance. The decision to broaden membership to the wider supply chain reflects the changing shape of the Specials market, particularly over the last 5 years following the introduction of the Specials Tariff alongside a developing regulatory framework and professional guidance around Specials.  Influencing and responding to issues in this changing market has also become a more important role for the APSM. APSM Chair, Sharon Griffiths, said, “The decisions and actions we take n...
Read more

Comment on article in Daily Mail Good Health

25th January 2011 Following a recent article in the Daily Mail the ACSM, Association of Commercial Specials Manufacturers, is keen to reassure patients of the need for specials or unlicensed medicines.    The article raised questions about the necessity of providing specially prepared liquid forms of common medicines for some patients.   Although the ACSM cannot comment on the details of the drug preparation in the article, in general, unlicensed medicines are prescribed by a doctor to meet a patient’s specific clinical need, for example, allergy to drug excipients or inability to swallow.   In these instances a doctor may decide to prescribe a special if there is no licensed alternative available to give to the patient.   Splitting and crushing tablets is not a satisfactory alternative as it does not always result in the patient receiving the correct formulation leading to a patient getting a much higher or much lower dose than is prescribed. ...
Read more